Skip to main content
. 2015 Nov 5;18(1):40–48. doi: 10.1111/dom.12574

Figure 3.

DOM-12574-FIG-0003-c

Insulin dose at end‐of‐trial according to baseline HbA1c category in DUAL I (A) and DUAL II (B). Data are mean dose (U) from the safety analysis set, last observation carried forward. Error bars are standard error of the mean. EOT, end‐of‐trial; IDeg, insulin degludec; IDegLira, insulin degludec/liraglutide combination.